Back to Search
Start Over
Pfizer Reports Top-Line Results of EU Post-Authorization Safety and Efficacy Study of Lyrica's Discontinuation Effects In Patients with Generalized Anxiety Disorder
- Source :
- Biotech Week. August 8, 2012, 258
- Publication Year :
- 2012
-
Abstract
- By a News Reporter-Staff News Editor at Biotech Week -- Pfizer Inc. (NYSE: PFE) announced that top-line results for Lyrica® (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy [...]
Details
- Language :
- English
- ISSN :
- 15352757
- Database :
- Gale General OneFile
- Journal :
- Biotech Week
- Publication Type :
- News
- Accession number :
- edsgcl.299126668